(1 - 13 von 13
)
Appointment of COO - Antisoma PLC - InvestEgateInvestegate
www.investegate.co.uk
— Antisoma PLC 25 February Ursula Ney joins Antisoma as Chief Operating Officer London, UK, 25 February Antisoma plc, ... › rns
Swiss biotech Genkyotex eyes IPO in second half of | Reuters
www.reuters.com
"It has become a serious option for us," Chief Executive Ursula Ney told Reuters. "We're looking at all markets: at our home market and ...
Guardian: Antisoma executive leaves after drug failure - The GuardianThe Guardian
— The company said Dr Ursula Ney left yesterday as part of a wider restructuring following news on Monday that a lung cancer drug it developed ... › ...
Antisoma Announces Departure Of COO Ursula Ney - Quick Facts
www.rttnews.com
L) announced that its Chief Operating Officer, Ursula Ney, has left the Company and the Antisoma Board, effective 31 March. The company said ...
Proteome News Headlines. PRM Share News. Financial News ...London South East
www.lse.co.uk
Scancell Hires Former Genkyotex Boss Ursula Ney As Non-Executive ... (Alliance News) - Scancell Holdings PLC on Wednesday said it has appointed Ursula Ney as a ... › PRM › sc...
131st Summer Meeting - The Virginia Bar AssociationThe Virginia Bar Association
www.vba.org
Ursula Ney. RSVP Comments: N/A. Attending: Yes. Bernard Niemeier. RSVP Comments: N/A. Attending: Yes. Daniel Ortiz. RSVP Comments: N/A. Attending: Yes. › RSVPlist
Charles Antis Roofing & Waterproofing, Inc. | (949) AllBiz
www.allbiz.com
They include: Ursula Ney, Manuel Cortez, Devin Winch, Erek Antis, Ramon Perez, Laura Taylor, Luis Martinez & Dean Morrison. › business
Genkyotex gets US FDA nod to begin phase II study of ...Pharmabiz.com
test.pharmabiz.com
... preclinical and Phase I data package as well as approval for our phase II clinical trial design,” said Ursula Ney, Genkyotex's chief executive officer. › news
Scancell Hlds - Final Results for the year ended 30 April 2020Aquis Exchange
www.aquis.eu
Martin Diggle and Dr Ursula Ney appointed as Non-Executive Directors to the Board, with Dr Matthew Frohn standing down on 31 October › announce...
GenKyoTex raises CHF18m in funding - Manufacturing ChemistManufacturing Chemist
www.manufacturingchemist.com
— GKT is the leading NOX1/4 inhibitor and will enter Phase I trials later this year. GenKyoTex has also appointed Ursula Ney, former coo at ... › ...
Genkyotex' Lead Product Shows Promise in OsteoporosisStartupticker.ch
www.startupticker.ch
— In our studies we found that NOX4 was induced in human osteoporosis, and inhibiting NOX4 could reduce bone loss in mice.” Dr. Ursula Ney, CEO of ... › news
Weinfest im Kursana Domizil SiegenDussmann Group
news.dussmanngroup.com
— Ursula Ney, 75, und Jochen Achenbach, 67, taxierten die vom Geschäftsführer der Stiftung Andreas Kornmann mitgebrachte Traubendolde zielsicher ... › news › weinfest-im-k...
Women in Biotech Networking Evening - March | BIABioIndustry Association
www.bioindustry.org
— 18:30 – 18:45: Ursula Ney, NED Proteome Sciences – : Denise Scots-Knight, Mereo Biopharma – 19:15: Q&A with all speakers. › wo...
sortiert nach Relevanz / Datum